Results 131 to 140 of about 16,337 (195)

Hereditary red cell defects as an underrecognized cause of neonatal jaundice. [PDF]

J Perinatol
Komvilaisak P, Wichajarn K, Laoaroon N, Paopongsawan P, Jirapradittha J, Kiatchoosakun P, Suwannaying K, Sawatjui N, Komwilaisak R, Kachenchat R.   +9 more
europepmc   +1 more source

A Rare Case of Homozygous HbE With Coinherited Alpha-Thalassemia and Hb Constant Spring in a Neonate Reveals a Mild Hematologic Phenotype. [PDF]

J Pediatr Hematol Oncol
Bobée V, Souissi M, Dumesnil C, Plouchart T, Pissard S, Galacteros F, Moutereau S.   +6 more
europepmc   +1 more source

Transfusion strategies in hemoglobinopathies: what the latest update of Good Practices tells us in the era of new therapeutic advances. [PDF]

Blood Transfus
Schieppati F.
europepmc   +1 more source

Protein Arginine Methyltransferases in γ-Globin Regulation and Sickle Cell Disease: Emerging Connections to Oxidative Stress. [PDF]

Antioxidants (Basel)
Chauhan W, Zennadi R.
europepmc   +1 more source

Gene Therapy of Beta Hemoglobinopathies. [PDF]

Biomedicines
Testa U, Pelosi E, Castelli G.
europepmc   +1 more source

Genetic disorders and congenital anomalies in Nigeria: a scoping review. [PDF]

J Community Genet
Babalola AD, Muniz NF, Schuler-Faccini L.   +2 more
europepmc   +1 more source

A Retrospective Analysis of Blood Component Utilization and Transfusion-Related Factors in a Diverse Patient Population. [PDF]

Healthcare (Basel)
Almujali YA, Darwish NM, Ba Abbad AA, Tamim H, Sajid MR, Saleem RA, Binjomah A, Aldosari K.   +7 more
europepmc   +1 more source

Hemoglobinopathies.

JPMA. The Journal of the Pakistan Medical Association, 1976
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hemoglobinopathies

Hematology, 2003
AbstractThe outlook for patients with sickle cell disease has improved steadily during the last two decades. In spite of these improvements, curative therapies are currently available only to a small minority of patients. The main theme of this chapter is to describe new therapeutic options that are at different stages of development that might result ...
George F, Atweh, Joseph, DeSimone, Yogen, Saunthararajah, Hassana, Fathallah, Rona S, Weinberg, Ronald L, Nagel, Mary E, Fabry, Robert J, Adams   +7 more
openaire   +2 more sources